CURATOLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 65.410
AS - Asia 6.390
EU - Europa 5.465
SA - Sud America 1.102
AF - Africa 107
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 9
Totale 78.520
Nazione #
US - Stati Uniti d'America 65.226
SG - Singapore 3.057
CN - Cina 1.094
BR - Brasile 890
UA - Ucraina 845
DE - Germania 827
RU - Federazione Russa 752
IT - Italia 694
HK - Hong Kong 656
IE - Irlanda 648
VN - Vietnam 540
FR - Francia 481
GB - Regno Unito 334
KR - Corea 290
FI - Finlandia 228
JP - Giappone 202
PL - Polonia 181
NL - Olanda 129
SE - Svezia 120
IN - India 119
CA - Canada 97
AR - Argentina 79
BD - Bangladesh 59
ID - Indonesia 52
MX - Messico 52
IQ - Iraq 50
TR - Turchia 45
AT - Austria 40
ES - Italia 38
TW - Taiwan 38
AU - Australia 34
ZA - Sudafrica 31
EC - Ecuador 30
BE - Belgio 29
CO - Colombia 27
CZ - Repubblica Ceca 25
MY - Malesia 21
VE - Venezuela 21
MA - Marocco 20
CL - Cile 19
PH - Filippine 19
UZ - Uzbekistan 19
PK - Pakistan 17
SA - Arabia Saudita 16
KE - Kenya 15
RO - Romania 14
DZ - Algeria 13
PE - Perù 12
TH - Thailandia 12
GR - Grecia 11
IR - Iran 10
LT - Lituania 10
PT - Portogallo 10
CH - Svizzera 9
EG - Egitto 9
KG - Kirghizistan 9
NP - Nepal 9
PY - Paraguay 9
UY - Uruguay 9
AL - Albania 8
CR - Costa Rica 8
KZ - Kazakistan 8
AE - Emirati Arabi Uniti 7
HU - Ungheria 7
IL - Israele 7
EU - Europa 6
TN - Tunisia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
JO - Giordania 5
LB - Libano 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
ET - Etiopia 3
HN - Honduras 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
KW - Kuwait 2
LK - Sri Lanka 2
MM - Myanmar 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SM - San Marino 2
SV - El Salvador 2
CG - Congo 1
CY - Cipro 1
Totale 78.502
Città #
Woodbridge 18.905
Wilmington 17.228
Houston 14.267
Fairfield 2.321
Singapore 1.694
Ann Arbor 1.506
Ashburn 1.155
Seattle 893
Chandler 830
Cambridge 822
San Jose 752
Jacksonville 728
Hong Kong 638
Dublin 610
Medford 482
Dearborn 434
Beijing 428
Santa Clara 331
Lawrence 227
New York 223
The Dalles 212
Los Angeles 200
Rome 182
Ho Chi Minh City 168
Kraków 155
Tokyo 146
Lauterbourg 145
Buffalo 129
Moscow 129
Hanoi 128
Council Bluffs 117
Dallas 110
San Diego 110
Menlo Park 94
Norwalk 94
Chicago 86
Mülheim 85
Munich 71
São Paulo 67
Milan 63
London 59
Nuremberg 49
Redwood City 47
Redondo Beach 40
Zhengzhou 38
University Park 37
Boardman 34
Taipei 34
Helsinki 33
Jakarta 33
Frankfurt am Main 32
Verona 32
Toronto 29
Chennai 28
Haiphong 28
Rio de Janeiro 28
Salt Lake City 28
Falls Church 27
Shanghai 27
North Bergen 26
Belo Horizonte 25
Mountain View 25
Nanjing 25
Seoul 25
Montreal 24
Phoenix 24
Saint Petersburg 24
Brno 23
Hyderabad 23
Warsaw 23
Da Nang 22
Denver 22
Orem 22
Brussels 20
Guangzhou 20
Kunming 19
Lappeenranta 19
Nijmegen 19
San Francisco 19
San Mateo 19
Amsterdam 18
Brasília 18
Poplar 18
Stockholm 18
Vienna 18
Atlanta 16
Brooklyn 16
Curitiba 16
Detroit 15
Dhaka 15
Hefei 15
Mexico City 15
Charlotte 14
Columbus 14
Johannesburg 14
Mumbai 14
Tashkent 14
Boston 13
Elk Grove Village 13
Melbourne 13
Totale 68.403
Nome #
Current role of perampanel in pediatric epilepsy 529
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 497
Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study 495
Human endogenous retroviruses and ADHD 487
Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders? 482
Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations 481
Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options. 476
Association between presenilin-1 -48C/T polymorphism and Down's syndrome 476
Association study of autistic disorder and chromosome 16p 468
ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity? 466
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 463
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. 461
Adhd and human endogenous retroviruses 459
Tourette syndrome and comorbid ADHD: causes and consequences 458
Two epileptic syndromes, one brain: Childhood absence epilepsy and benign childhood epilepsy with centrotemporal spikes 451
Association of adenosine deaminase polymorphism with mild mental retardation 449
Comorbidity of ADHD and dyslexia. 449
Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. 447
Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders 447
mTOR Inhibitors in Tuberous Sclerosis Complex. 447
Impairment in flexible regulation of speed and accuracy in children with ADHD 447
The association of rs4307059 and rs35678 markers with autism spectrum disorders is replicated in Italian families 446
Website and Headache: Assessment of The Information Quality using the DISCERN Tool 445
Interstitial deletion of a proximal 3p: a clinically recognisable syndrome 444
Convulsive disorder and the genetics of signal transduction; a study of a low molecular weight protein tyrosine phosphatase in a pediatric sample 441
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 440
Current role of melatonin in pediatric neurology: Clinical recommendations 438
Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism 433
Long term clinical course of Tourette syndrome. 433
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 433
MTHFR C677T and A1298C polymorphisms and cerebral stroke in two twin gestations 432
Cortical maldevelopment in congenital cytomegalovirus infection transmitted by a woman with preexisting immunity. 431
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 430
Can biological components predict short-term evolution in Autism Spectrum Disorders? A proof-of-concept study 428
Lack of association between IDE genetic variability and Down's syndrome 426
Efficacy of intensive versus nonintensive physiotherapy in children with cerebral palsy: a meta-analysis. 426
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 426
Optical coherence tomography and infrared images of astrocytic hamartomas not revealed by funduscopy in tuberous sclerosis complex 425
Management of epilepsy in tuberous sclerosis complex 424
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 423
Attention and executive functions profile in drug naive ADHD subtypes 422
Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. 422
Cluster analysis of autistic patients based on principal pathogenetic components. 422
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 422
Epilepsy in tuberous sclerosis complex. 421
Medical treatment in children with central nervous system malformations 421
Conceptual and methodological challenges for neuroimaging studies of autistic spectrum disorders. 421
Urinary p-cresol is elevated in small children with severe autism spectrum disorder. 420
Use of the DISCERN tool for evaluating web searches in childhood epilepsy. 420
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 420
Candidate gene study of HOXB1 in autism spectrum disorder. 418
De novo mosaic ring chromosome 18 in a child with mental retardation, epilepsy and immunological problems 418
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients. 417
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 415
Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. 414
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 414
Methylphenidate-induced visual hallucinations. 413
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 413
The neurobiology of attention deficit/hyperactivity disorder. 412
Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014. 412
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. 411
Child neurology: role of the International Association. 410
Long-term neurological outcome of a sextuplet pregnancy. 410
Detection of auto-antibodies to DAT in the serum: interactions with DAT genotype and psycho-stimulant therapy for ADHD. 410
Refractory absence seizures: An Italian multicenter retrospective study 410
Syndromic autism: Causes and pathogenetic pathways 409
Hypnic headache in children. 409
Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation 408
Effectiveness of community-based treatment on clinical outcome in children with autism spectrum disorders: An Italian prospective study. 408
Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities 407
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 407
Two-loci ADA haplotypes in autistic disorder 406
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 405
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 404
Early-onset pure absence epilepsy: a distinct epileptic syndrome. 404
Recommendations for early diagnosis and intervention in autism spectrum disorders: an Italian-Israeli consensus conference 404
Autism in tuberous sclerosis 403
HERVs expression in autism spectrum disorders 403
Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link? 402
Lack of association between MTHFR C677T and MTHFR A1298C genetic polymorphisms and mental retardation 400
Attention and executive functions profile in childhood absence epilepsy. 400
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 400
Autism: evidence of association with adenosine deaminase genetic polymorphism 399
Late-onset epileptic spasms in children with Pallister-Killian syndrome: a report of two new cases and review of the electroclinical aspects. 399
Preterm birth and neurodevelopmental outcome: a review 399
Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: Significant clinical improvement during tamoxifen treatment 398
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. 398
Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations 398
Altered anandamide degradation in attention-deficit/hyperactivity disorder 397
Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome 397
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 397
MRI appearance of Sturge-Weber syndrome in tuberous sclerosis complex: is the neural crest the culprit? 395
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 395
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 395
Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects 394
Rufinamide for refractory focal seizures: an open-label, multicenter European study. 393
Introduction. 392
Genetic polymorphism and idiopathic generalized epilepsy. Evidence of interaction between haptoglobin and ACP1 systems 390
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 390
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 389
Totale 42.461
Categoria #
all - tutte 175.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021566 0 0 0 0 0 0 0 0 0 0 447 119
2021/20222.011 95 200 83 44 40 201 109 80 206 180 175 598
2022/20232.384 267 198 61 233 213 611 244 139 190 12 158 58
2023/2024744 121 20 45 7 58 189 26 19 19 22 52 166
2024/20255.287 146 1.344 680 312 108 339 413 235 406 659 298 347
2025/20267.054 582 382 958 624 781 241 951 938 985 600 12 0
Totale 79.094